APA (7th ed.) Citation

Strachota, S., Malysiak-Szpond, S., Binowski, G., Ksiazek, P., Sutherland, C., & Pruszko, C. (2024). EE741 Budget Impact Analysis of Risdiplam in the Treatment of Newborn Spinal Muscular Atrophy Patients in Poland. Value in Health, 27(12), S201. https://doi.org/10.1016/j.jval.2024.10.1021

Chicago Style (17th ed.) Citation

Strachota, S., S. Malysiak-Szpond, G. Binowski, P. Ksiazek, CS Sutherland, and C. Pruszko. "EE741 Budget Impact Analysis of Risdiplam in the Treatment of Newborn Spinal Muscular Atrophy Patients in Poland." Value in Health 27, no. 12 (2024): S201. https://doi.org/10.1016/j.jval.2024.10.1021.

MLA (9th ed.) Citation

Strachota, S., et al. "EE741 Budget Impact Analysis of Risdiplam in the Treatment of Newborn Spinal Muscular Atrophy Patients in Poland." Value in Health, vol. 27, no. 12, 2024, p. S201, https://doi.org/10.1016/j.jval.2024.10.1021.